COVID-19 Response

Vaccine Eligibility & Information, Safety Protocols, Research and Visitor Guidelines. Learn More

CHRISTUS Good Shepherd Medical Center - Marshall Receives Get With The Guidelines-Stroke Gold Plus Core and Quality Measures Award June 21, 2018

 

MARSHALL, TX ― CHRISTUS Good Shepherd Medical Center - Marshall has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

CHRISTUS Good Shepherd Medical Center - Marshall earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

“CHRISTUS Good Shepherd Health System and CHRISTUS Good Shepherd Medical Center - Marshall are dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get With The Guidelines-Stroke initiative,” said Mark Anderson, M.D., Chief Medical Officer of CHRISTUS Good Shepherd Health System. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes.”

CHRISTUS Good Shepherd Medical Cneter - Marshall additionally received the association’s (Target: StrokeSM Elite Honor Roll) award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. To earn Target Stroke Elite Honor Roll status, CHRISTUS Good Shepherd Medical Center - Marshall maintained a minimum of 75% of tPA door-to-needle times less than 60 minutes.

“We are pleased to recognize CHRISTUS Good Shepherd Medical Center - Marshall for their commitment to stroke care,” said Eric E. Smith, M.D., national chairman of the Get With The Guidelines Steering Committee and an associate professor of neurology at the University of Calgary in Alberta, Canada. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.